cuprizone has been researched along with Multiple Sclerosis, Chronic Progressive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Branton, WG; Doan, MAL; Fernandes, JP; Major, EO; Monaco, MC; Power, C; Saito, LB; Schmitt, LM; Smith, MJ; Wuest, F; Wuest, M | 1 |
| Banda, E; Castro-Borrero, W; Crocker, SJ; Guzzo, RM; Johnson, KM; Lo, AC; Nicaise, AM; Russomanno, K; Willis, CM | 1 |
| Brück, W; Grønborg, M; Jürgens, T; Kreutzfeldt, M; Kuhlmann, T; Manrique-Hoyos, N; Merkler, D; Schedensack, M; Schrick, C; Simons, M; Urlaub, H | 1 |
3 other study(ies) available for cuprizone and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
Intranasal anti-caspase-1 therapy preserves myelin and glucose metabolism in a model of progressive multiple sclerosis.
Topics: Animals; Caspase 1; Cuprizone; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Mice; Mice, Inbred C57BL; Multiple Sclerosis, Chronic Progressive; Myelin Sheath | 2021 |
iPS-derived neural progenitor cells from PPMS patients reveal defect in myelin injury response.
Topics: Aged; Animals; Apoptosis; Axons; Cell Differentiation; Clemastine; Culture Media, Conditioned; Cuprizone; Female; Humans; Induced Pluripotent Stem Cells; Male; Mice, Inbred C57BL; Miconazole; Middle Aged; Monoamine Oxidase Inhibitors; Multiple Sclerosis, Chronic Progressive; Myelin Basic Protein; Myelin Sheath; Nerve Tissue Proteins; Oligodendroglia | 2017 |
Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis.
Topics: Aging; Animals; Axons; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Skills; Multiple Sclerosis, Chronic Progressive; Myelin Sheath; Time Factors | 2012 |